Logo image
Sign in
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
Journal article   Open access   Peer reviewed

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Julio Dávila-Valls, Sonia Martín-Pérez, Andreas Glenthøj, Ditte Stampe Hersby, Maria Gomes da Silva, …
EClinicalMedicine, Vol.71
05/2024
PMCID: PMC10963230
PMID: 38533127

Abstract

COVID-19 Haematological malignancy ICU Immunosuppression Vaccination
The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits for these patients may not be as pronounced.
url
Find in HALView
url
https://doi.org/10.1016/j.eclinm.2024.102553View
Published (Version of record) Open

Metrics

1 Record Views

Details

Logo image